X
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LIRAGLUTIDE RECOMBINANT, with a corresponding application number 22341 and regulatory information .
proudly manufactured in the
approval since 2010-01-25
Novo Nordisk's VICTOZA SOLUTION;SUBCUTANEOUS, medication with 18MG/3ML (6MG/ML) of LIRAGLUTIDE RECOMBINANT.